Q3 2023 · 13F-HR
Samsara BioCapital, LLCholdings as filed
Filed 2023-11-14 · accession 0001104659-23-118112
$326.7M
Reported value
41
Positions
2023-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $43.0M | 13.2% | 4,519,361 | Common | SOLE |
| 75525N107 | — | RAYZEBIO INC | $41.0M | 12.5% | 1,845,948 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $32.7M | 9.99% | 4,598,828 | Common | SOLE |
| 00445A100 | — | ACELYRIN INC | $24.2M | 7.41% | 2,381,579 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $22.0M | 6.74% | 613,921 | Common | SOLE |
| 38870X104 | GRPH | GRAPHITE BIO INC | $21.0M | 6.42% | 8,459,314 | Common | SOLE |
| 45845P108 | — | INTERCEPT PHARMACEUTICALS IN | $11.9M | 3.64% | 640,688 | Common | SOLE |
| 55234L105 | LYRAGBP | LYRA THERAPEUTICS INC | $10.9M | 3.33% | 2,780,261 | Common | SOLE |
| 43157M102 | — | HILLEVAX INC | $10.8M | 3.29% | 799,274 | Common | SOLE |
| 05337M104 | — | AVADEL PHARMACEUTICALS PLC | $10.0M | 3.05% | 967,527 | Common | SOLE |
| 98985Y108 | ZYME | ZYMEWORKS INC | $9.2M | 2.83% | 1,458,875 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $7.9M | 2.42% | 345,293 | Common | SOLE |
| 87583X109 | TNGX | TANGO THERAPEUTICS INC | $7.1M | 2.17% | 630,000 | Common | SOLE |
| 45790W108 | — | INOZYME PHARMA INC | $6.6M | 2.01% | 1,562,500 | Common | SOLE |
| 869367102 | — | SUTRO BIOPHARMA INC | $5.8M | 1.78% | 1,675,579 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $5.7M | 1.73% | 347,500 | Common | SOLE |
| 449778109 | IOBTQ | IO BIOTECH INC | $5.1M | 1.57% | 3,640,015 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $5.1M | 1.56% | 6,130,268 | Common | SOLE |
| 00461U105 | ACRS | ACLARIS THERAPEUTICS INC | $4.8M | 1.46% | 696,171 | Common | SOLE |
| N44445109 | IMTX | IMMATICS N.V | $4.6M | 1.40% | 396,000 | Common | SOLE |
| 74168J101 | PRME | PRIME MEDICINE INC | $4.5M | 1.37% | 470,304 | Common | SOLE |
| 45258D105 | IMCR | IMMUNOCORE HLDGS PLC | $4.2M | 1.29% | 80,963 | Common | SOLE |
| 65487U108 | NKTX | NKARTA INC | $4.0M | 1.22% | 2,868,035 | Common | SOLE |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $3.6M | 1.11% | 360,414 | Common | SOLE |
| 87184Q206 | SYRS | SYROS PHARMACEUTICALS INC | $3.5M | 1.07% | 881,450 | Common | SOLE |
| 30233G209 | EYPT | EYEPOINT PHARMACEUTICALS INC | $3.5M | 1.06% | 432,000 | Common | SOLE |
| 713317105 | PEPG | PEPGEN INC | $3.3M | 1.01% | 651,050 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $2.4M | 0.74% | 196,425 | Common | SOLE |
| 75082Q105 | — | RAIN ONCOLOGY INC | $1.8M | 0.54% | 2,034,552 | Common | SOLE |
| 449585108 | 1K0 | IGM BIOSCIENCES INC | $1.3M | 0.40% | 154,664 | Common | SOLE |
| 097702104 | BOLT1EUR | BOLT BIOTHERAPEUTICS INC | $1.1M | 0.33% | 1,049,153 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $1.0M | 0.31% | 202,348 | Common | SOLE |
| 52187K200 | CYPH | LEAP THERAPEUTICS INC | $831,040 | 0.25% | 602,203 | Common | SOLE |
| 918385105 | — | VTV THERAPEUTICS INC | $781,773 | 0.24% | 1,635,509 | Common | SOLE |
| 92765F108 | RYI | VIRACTA THERAPEUTICS INC | $717,297 | 0.22% | 689,709 | Common | SOLE |
| 01671P100 | ALLKGUSD | ALLAKOS INC | $390,642 | 0.12% | 172,089 | Common | SOLE |
| 808644108 | — | SCIENCE 37 HOLDINGS INC | $360,000 | 0.11% | 900,000 | Common | SOLE |
| 019818103 | — | ALLOVIR INC | $177,022 | 0.05% | 82,336 | Common | SOLE |
| 50107A104 | KRON1USD | KRONOS BIO INC | $101,570 | 0.03% | 78,131 | Common | SOLE |
| 67080N119 | NUVB/WS | NUVATION BIO INC | $13,333 | 0.00% | 133,333 | Common | SOLE |
| 86889P117 | SRZNW | SURROZEN INC | $4,110 | 0.00% | 99,999 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.